|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM241501962 |
003 |
DE-627 |
005 |
20231224124410.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2014 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2014.08.009
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0805.xml
|
035 |
|
|
|a (DE-627)NLM241501962
|
035 |
|
|
|a (NLM)25178982
|
035 |
|
|
|a (PII)S1521-6616(14)00200-9
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Shen, Long
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome
|
264 |
|
1 |
|c 2014
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 26.01.2015
|
500 |
|
|
|a Date Revised 31.03.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2014 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Sjogren's syndrome (SS) has been associated with the expression of anti-Ro and anti-La antibodies. Anti-salivary gland protein 1 (SP1) antibodies have recently been identified in patients with SS. The current work involved a cross sectional study to determine whether anti-SP1 antibodies were identified in particular subgroups of patients with SS. The results of this study revealed that anti-SP1 antibodies were present in the sera of 52% of SS patients while anti-Ro/anti-La was present in 63% of patients. 19% of patients had anti-SP1 without anti-Ro/anti-La. Patients with SS and lymphoma expressed anti-Ro, anti-La and anti-SP1 together. In SS associated with RA, 50% had antibodies anti-SP1 while 40% had anti-Ro/anti-La. In conclusion, anti-SP1 antibodies are commonly seen in both primary and secondary SS and rarely in normal controls. Future studies are needed to determine the roles and timing of expression of anti-SP1 antibodies in Sjogren's syndrome
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Anti-La;
|
650 |
|
4 |
|a Anti-Ro;
|
650 |
|
4 |
|a Anti-salivary gland protein 1 (SP1)
|
650 |
|
4 |
|a Rheumatoid arthritis;
|
650 |
|
4 |
|a Sjogren's syndrome;
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a Salivary Proteins and Peptides
|2 NLM
|
700 |
1 |
|
|a Kapsogeorgou, Efstathia K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yu, Meixing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Suresh, Lakshmanan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Malyavantham, Kishore
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tzioufas, Anthanasios G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ambrus, Julian L
|c Jr
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 155(2014), 1 vom: 12. Nov., Seite 42-46
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:155
|g year:2014
|g number:1
|g day:12
|g month:11
|g pages:42-46
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2014.08.009
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 155
|j 2014
|e 1
|b 12
|c 11
|h 42-46
|